Anastrozole(Arimidex)
Inquiry
| Post Date: | Oct 23,2014 |
| Expiry Date: | Apr 21,2015 |
| Detailed Description: |
Anastrozole(Arimidex)
CAS No： 120511-73-1 Molecular formula： 120511-73-1 Molecular weight： 293.37 Appearance： White powder. Assay： 99% Delivery time： 5-7 business days door-to-door Minimum order： 1g Supply ability： 10kg per mouth Quality standard： USP 35 Product details: Anastrozole is an aromatase-inhibiting drug approved for treatment of breast cancer after surgery, as well as for metastasis in both pre and postmenopausal women. The severity of breast cancer is increased by estrogen, as sexhormones cause hyperplasia, and differentiation at estrogen receptor sites. Anastrozole works by inhibiting the synthesis of estrogen. The trial suggested that anastrozole is the preferred medical therapy for Postmenopausal women with localized breast cancer that is estrogen receptor (ER) positive. Three azole potent selective aromatase inhibitors, which inhibit rely on aromatase cytochrome P -450 to block estrogen biosynthesis, and the main factors of estrogen to stimulate breast cancer cell growth. It can treat breast cancer, especially suitable for those who relapse after treatment with hormone auxiliary advanced breast cancer after menopause women. |
| Company: | HugeRaw Health Technology Co., Ltd [ China ] |
| Contact: | diana |
| Tel: | +86-571-12345678 |
| Fax: | +86-571-12345678 |
| Email: | diana.hugeraw@Safe-mail.net |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
